2-232521438-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001195129.2(PRSS56):c.205+10C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,532,842 control chromosomes in the GnomAD database, including 185 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 21 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 164 hom. )
Consequence
PRSS56
NM_001195129.2 intron
NM_001195129.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0420
Genes affected
PRSS56 (HGNC:39433): (serine protease 56) This gene encodes a protein that contains a peptidase S1 domain and possesses trypsin-like serine protease activity. The encoded protein may play a role in eye development, and mutations in this gene are a cause of autosomal recessive posterior microphthalmos. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 2-232521438-C-G is Benign according to our data. Variant chr2-232521438-C-G is described in ClinVar as [Benign]. Clinvar id is 707140.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0877 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRSS56 | NM_001195129.2 | c.205+10C>G | intron_variant | ENST00000617714.2 | NP_001182058.1 | |||
PRSS56 | NM_001369848.1 | c.205+10C>G | intron_variant | NP_001356777.1 | ||||
PRSS56 | XM_047445431.1 | c.205+10C>G | intron_variant | XP_047301387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRSS56 | ENST00000617714.2 | c.205+10C>G | intron_variant | 5 | NM_001195129.2 | ENSP00000479745 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00352 AC: 536AN: 152184Hom.: 21 Cov.: 33
GnomAD3 genomes
AF:
AC:
536
AN:
152184
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00772 AC: 1037AN: 134362Hom.: 45 AF XY: 0.00760 AC XY: 556AN XY: 73186
GnomAD3 exomes
AF:
AC:
1037
AN:
134362
Hom.:
AF XY:
AC XY:
556
AN XY:
73186
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00265 AC: 3654AN: 1380540Hom.: 164 Cov.: 30 AF XY: 0.00273 AC XY: 1860AN XY: 681494
GnomAD4 exome
AF:
AC:
3654
AN:
1380540
Hom.:
Cov.:
30
AF XY:
AC XY:
1860
AN XY:
681494
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00353 AC: 538AN: 152302Hom.: 21 Cov.: 33 AF XY: 0.00432 AC XY: 322AN XY: 74454
GnomAD4 genome
AF:
AC:
538
AN:
152302
Hom.:
Cov.:
33
AF XY:
AC XY:
322
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
82
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 14, 2018 | - - |
Isolated microphthalmia 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
PRSS56-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 16
Find out detailed SpliceAI scores and Pangolin per-transcript scores at